Lung Cancer Screening Prevalence and Changes in 2024 - Top-Institutions - MDSpire

Lung Cancer Screening Prevalence and Changes in 2024

  • By

  • Todd Burus

  • Caree R. McAfee

  • Jennifer Redmond Knight

  • Timothy W. Mullett

  • Pamela C. Hull

  • June 1, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    National Lung Screening Trial
    National Lung Screening Trial

    Bethesda, MD

    Key Differentiators

    • Lung Cancer Screening

  • #2

    National Cancer Institute
    National Cancer Institute

    Bethesda, MD

    Key Differentiators

    • Cancer Research

  • #3

    U.S. Preventive Services Task Force
    U.S. Preventive Services Task Force

    Rockville, MD

    Key Differentiators

    • Preventive Services

  • #4

    Lung Cancer Alliance
    Lung Cancer Alliance

    Washington, DC

    Key Differentiators

    • Lung Cancer Advocacy

Original Source(s)

Lung Cancer Screening Prevalence and Changes in 2024

  • by Todd Burus, Caree R. McAfee, Jennifer Redmond Knight, Timothy W. Mullett, Pamela C. Hull

  • June 1, 2026

Related Content

An LDH-based prognostic model for extensive-stage small-cell lung cancer patients treated with chemo-immunotherapy and consolidative thoracic radiotherapy

Targeted therapy combined with local consolidative surgery for oligometastatic stage IVA lung adenocarcinoma with CCDC6-RET fusion: a case report

Four-dimensional computed tomography ventilation imaging-guided radiotherapy planning in different techniques for lung cancer